CUPERTINO, CALIFORNIA / ACCESS Newswire / March 17, 2025 / Infinx, a leader in AI-powered revenue cycle management solutions, announces the acquisition of Glidian, a market leader in prior authorization automation. The strategic move strengthens Infinx's patient access solutions while expanding its footprint in the laboratory market, where Glidian has established itself as a leader.
Glidian was founded with the mission of automating prior authorizations to ensure patients receive timely access to healthcare. By combining technology and services, Glidian has achieved comprehensive market coverage. Infinx shares this vision, making the acquisition a natural fit for both companies.
"This partnership is an exciting step forward for both organizations," said Jaideep Tandon, CEO of Infinx. "Glidian's expertise in prior authorization technology, particularly within the laboratory space, complements Infinx's suite of patient access solutions. We're excited to welcome the Glidian team to the Infinx family and look forward to continuing our relentless innovation to address the pain points in patient access and prior authorization. Together, we will deliver even greater value to healthcare providers and their patients."
The decision to integrate Glidian into Infinx comes at a pivotal moment. Both companies have built integrations with several nationwide payers, and by merging these connections, they will enhance efficiencies and streamline workflows for customers. Together, Infinx and Glidian now process an average of 700,000 patient access transactions per month, solidifying their position as a powerhouse in patient access automation.
By leveraging Infinx's advanced AI capabilities, Glidian customers will benefit from enhanced automation, improved accuracy, and accelerated prior authorization approvals. Infinx's AI-driven platform continuously learns and adapts to payer requirements, reducing administrative burden and helping healthcare organizations optimize their workflows. The combination of AI-powered intelligence with Glidian's established solutions will provide customers with a seamless, more efficient prior authorization process.
"Infinx's commitment to innovation and customer success makes them the perfect partner for Glidian," said Ashish Dua CEO of Glidian. "With Infinx's resources and expertise, we can further accelerate prior authorization automation and expand our product offerings, ultimately improving the patient access experience for all."
For more information on prior authorization solutions, visit https://www.infinx.com/prior-authorization-solution/. To learn more about the Infinx Revenue Cycle Agent Platform, visit https://www.infinx.com/revenue-cycle-agent-platform/.
About Infinx
Founded in 2012, Infinx provides AI-driven solutions to optimize the financial lifecycle of healthcare providers across all functions of patient access and revenue cycle management. Our cloud-based software, powered by AI and automation, is leveraged by experienced consultants and billing specialists across the U.S., India, and the Philippines. We help 172,000 healthcare professionals across 4,000 facilities capture more revenue, stay ahead of changing regulations and payer guidelines, and focus on patient care. For more information, visit www.infinx.com.
About Glidian
Glidian is a leading provider of prior authorization automation solutions for the laboratory space, dedicated to simplifying the healthcare authorization process. With integrations across thousands of payers, Glidian processes over one million authorizations annually, serving more than 92,000 providers nationwide. By leveraging technology and a team of prior authorization specialists, Glidian enhances revenue capture, improves operational efficiency, and accelerates patient care.
Contact Information
Erin Wabol
AVP, Communications
erin.wabol@infinx.com
SOURCE: Infinx Healthcare
View the original press release on ACCESS Newswire
